The ARTO™ System - Transcatheter Annular Reduction Therapy - our simple, one size technology to treat functional mitral regurgitation.

Image description

The ARTO™ System targets functional mitral valve regurgitation associated with congestive heart failure through direct shortening of the minor axis of the mitral valve. Its venous based delivery results in a stress-free, simple procedure that won't affect future therapy.

"The ARTO System is a unique solution to treating FMR. The device is safe, the procedure is simple, and the benefit to the patient is almost immediate."

– Simon Redwood, MB, BS, MD, Honorary Consultant Cardiologist and Professor of Interventional Cardiology, St Thomas' Hospital, London, UK

tab photo

Innovative Therapy for CHF-related mitral valve regurgitation

The ARTO System reestablishes normal anatomic relationships of the mitral valve through a unique system designed to enhance heart function.
Learn More

Maveric Trial

MAVERIC Trials to demonstrate safety and performance

Our worldwide multi-centre clinical trials are designed to demonstrate that the device can be delivered safely and provide sustained improvement in CHF-related mitral regurgitation.
Learn More

News & Events

TCT 2020/TCT Connect
October 14-18, 2020

PCR London Valves 2020
November 22-24, 2020
London, UK